Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.05
MD's Cash to Debt is ranked lower than
84% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 0.30 vs. MD: 0.05 )
Ranked among companies with meaningful Cash to Debt only.
MD' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.62 Max: 312.43
Current: 0.05
0.01
312.43
Equity to Asset 0.52
MD's Equity to Asset is ranked higher than
64% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. MD: 0.52 )
Ranked among companies with meaningful Equity to Asset only.
MD' s 10-Year Equity to Asset Range
Min: 0.52  Med: 0.76 Max: 0.91
Current: 0.52
0.52
0.91
Interest Coverage 57.70
MD's Interest Coverage is ranked higher than
72% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 6.81 vs. MD: 57.70 )
Ranked among companies with meaningful Interest Coverage only.
MD' s 10-Year Interest Coverage Range
Min: 6.6  Med: 97.83 Max: 294.93
Current: 57.7
6.6
294.93
F-Score: 7
Z-Score: 3.76
M-Score: -3.01
WACC vs ROIC
7.58%
11.52%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 20.63
MD's Operating margin (%) is ranked higher than
87% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 7.35 vs. MD: 20.63 )
Ranked among companies with meaningful Operating margin (%) only.
MD' s 10-Year Operating margin (%) Range
Min: 10.23  Med: 22.55 Max: 26.38
Current: 20.63
10.23
26.38
Net-margin (%) 12.63
MD's Net-margin (%) is ranked higher than
83% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 3.55 vs. MD: 12.63 )
Ranked among companies with meaningful Net-margin (%) only.
MD' s 10-Year Net-margin (%) Range
Min: 4.52  Med: 14.62 Max: 16.21
Current: 12.63
4.52
16.21
ROE (%) 14.23
MD's ROE (%) is ranked higher than
69% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 9.02 vs. MD: 14.23 )
Ranked among companies with meaningful ROE (%) only.
MD' s 10-Year ROE (%) Range
Min: 4.67  Med: 13.93 Max: 17.59
Current: 14.23
4.67
17.59
ROA (%) 9.00
MD's ROA (%) is ranked higher than
80% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.66 vs. MD: 9.00 )
Ranked among companies with meaningful ROA (%) only.
MD' s 10-Year ROA (%) Range
Min: 3.33  Med: 11.04 Max: 12.77
Current: 9
3.33
12.77
ROC (Joel Greenblatt) (%) 314.47
MD's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 16.21 vs. MD: 314.47 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 59.95  Med: 486.88 Max: 755.09
Current: 314.47
59.95
755.09
Revenue Growth (3Y)(%) 14.50
MD's Revenue Growth (3Y)(%) is ranked higher than
79% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. MD: 14.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MD' s 10-Year Revenue Growth (3Y)(%) Range
Min: 6.9  Med: 14.50 Max: 45.1
Current: 14.5
6.9
45.1
EBITDA Growth (3Y)(%) 12.90
MD's EBITDA Growth (3Y)(%) is ranked higher than
66% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. MD: 12.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -1.1  Med: 12.90 Max: 53.8
Current: 12.9
-1.1
53.8
EPS Growth (3Y)(%) 12.60
MD's EPS Growth (3Y)(%) is ranked higher than
58% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. MD: 12.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MD' s 10-Year EPS Growth (3Y)(%) Range
Min: -20.6  Med: 13.30 Max: 71.7
Current: 12.6
-20.6
71.7
» MD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

MD Guru Trades in Q3 2014

Steven Cohen 330,900 sh (New)
Jim Simons 399,800 sh (+1246.13%)
Joel Greenblatt 909,227 sh (+338.64%)
Paul Tudor Jones 18,136 sh (+26.93%)
Mariko Gordon 66,825 sh (+23.83%)
Chuck Royce 887,514 sh (+0.43%)
Vanguard Health Care Fund 805,600 sh (unchged)
Jeremy Grantham 112,201 sh (-19.91%)
» More
Q4 2014

MD Guru Trades in Q4 2014

Vanguard Health Care Fund 805,600 sh (unchged)
Mariko Gordon 66,825 sh (unchged)
Steven Cohen Sold Out
Jim Simons 353,300 sh (-11.63%)
Jeremy Grantham 87,800 sh (-21.75%)
Chuck Royce 535,668 sh (-39.64%)
Paul Tudor Jones 8,800 sh (-51.48%)
Joel Greenblatt 88,300 sh (-90.29%)
» More
Q1 2015

MD Guru Trades in Q1 2015

Steven Cohen 116,100 sh (New)
Paul Tudor Jones 14,544 sh (+65.27%)
Jim Simons 460,300 sh (+30.29%)
Vanguard Health Care Fund 805,600 sh (unchged)
Joel Greenblatt 87,204 sh (-1.24%)
Mariko Gordon 57,957 sh (-13.27%)
Chuck Royce 406,433 sh (-24.13%)
Jeremy Grantham 66,100 sh (-24.72%)
» More
Q2 2015

MD Guru Trades in Q2 2015

Pioneer Investments 153,099 sh (New)
Steven Cohen 245,300 sh (+111.28%)
Vanguard Health Care Fund 805,600 sh (unchged)
Mariko Gordon 57,317 sh (-1.10%)
Chuck Royce 387,033 sh (-4.77%)
Joel Greenblatt 77,695 sh (-10.90%)
Jim Simons 371,000 sh (-19.40%)
Paul Tudor Jones 10,700 sh (-26.43%)
Jeremy Grantham 47,000 sh (-28.90%)
» More
» Details

Insider Trades

Latest Guru Trades with MD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.47
MD's P/E(ttm) is ranked higher than
55% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 27.50 vs. MD: 23.47 )
Ranked among companies with meaningful P/E(ttm) only.
MD' s 10-Year P/E(ttm) Range
Min: 6.96  Med: 17.88 Max: 26.65
Current: 23.47
6.96
26.65
Forward P/E 19.01
MD's Forward P/E is ranked lower than
53% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 19.23 vs. MD: 19.01 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 24.20
MD's PE(NRI) is ranked higher than
55% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 28.90 vs. MD: 24.20 )
Ranked among companies with meaningful PE(NRI) only.
MD' s 10-Year PE(NRI) Range
Min: 8  Med: 18.02 Max: 26.45
Current: 24.2
8
26.45
P/B 3.34
MD's P/B is ranked lower than
63% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. MD: 3.34 )
Ranked among companies with meaningful P/B only.
MD' s 10-Year P/B Range
Min: 1.23  Med: 2.38 Max: 3.59
Current: 3.34
1.23
3.59
P/S 2.98
MD's P/S is ranked lower than
75% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. MD: 2.98 )
Ranked among companies with meaningful P/S only.
MD' s 10-Year P/S Range
Min: 1.12  Med: 2.51 Max: 3.84
Current: 2.98
1.12
3.84
PFCF 19.00
MD's PFCF is ranked higher than
56% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 22.16 vs. MD: 19.00 )
Ranked among companies with meaningful PFCF only.
MD' s 10-Year PFCF Range
Min: 6.33  Med: 14.06 Max: 20.73
Current: 19
6.33
20.73
POCF 17.97
MD's POCF is ranked lower than
62% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.76 vs. MD: 17.97 )
Ranked among companies with meaningful POCF only.
MD' s 10-Year POCF Range
Min: 5.82  Med: 13.16 Max: 19.87
Current: 17.97
5.82
19.87
EV-to-EBIT 16.09
MD's EV-to-EBIT is ranked higher than
61% of the 166 Companies
in the Global Medical Care industry.

( Industry Median: 20.01 vs. MD: 16.09 )
Ranked among companies with meaningful EV-to-EBIT only.
MD' s 10-Year EV-to-EBIT Range
Min: -21.5  Med: 10.80 Max: 17.1
Current: 16.09
-21.5
17.1
PEG 2.14
MD's PEG is ranked higher than
63% of the 68 Companies
in the Global Medical Care industry.

( Industry Median: 2.77 vs. MD: 2.14 )
Ranked among companies with meaningful PEG only.
MD' s 10-Year PEG Range
Min: 0.6  Med: 1.19 Max: 2.15
Current: 2.14
0.6
2.15
Shiller P/E 29.63
MD's Shiller P/E is ranked lower than
52% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 30.14 vs. MD: 29.63 )
Ranked among companies with meaningful Shiller P/E only.
MD' s 10-Year Shiller P/E Range
Min: 9.69  Med: 23.03 Max: 35.64
Current: 29.63
9.69
35.64
Current Ratio 1.69
MD's Current Ratio is ranked higher than
65% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. MD: 1.69 )
Ranked among companies with meaningful Current Ratio only.
MD' s 10-Year Current Ratio Range
Min: 0.77  Med: 1.38 Max: 11.34
Current: 1.69
0.77
11.34
Quick Ratio 1.69
MD's Quick Ratio is ranked higher than
70% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. MD: 1.69 )
Ranked among companies with meaningful Quick Ratio only.
MD' s 10-Year Quick Ratio Range
Min: 0.77  Med: 1.38 Max: 11.34
Current: 1.69
0.77
11.34
Days Sales Outstanding 53.57
MD's Days Sales Outstanding is ranked lower than
63% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 46.02 vs. MD: 53.57 )
Ranked among companies with meaningful Days Sales Outstanding only.
MD' s 10-Year Days Sales Outstanding Range
Min: 46.59  Med: 59.50 Max: 124.98
Current: 53.57
46.59
124.98

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.17
MD's Price/Projected FCF is ranked higher than
67% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.53 vs. MD: 1.17 )
Ranked among companies with meaningful Price/Projected FCF only.
MD' s 10-Year Price/Projected FCF Range
Min: 0.46  Med: 1.04 Max: 3.76
Current: 1.17
0.46
3.76
Price/DCF (Earnings Based) 1.32
MD's Price/DCF (Earnings Based) is ranked higher than
65% of the 23 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. MD: 1.32 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.18
MD's Price/Median PS Value is ranked lower than
57% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. MD: 1.18 )
Ranked among companies with meaningful Price/Median PS Value only.
MD' s 10-Year Price/Median PS Value Range
Min: 0.2  Med: 0.98 Max: 3.99
Current: 1.18
0.2
3.99
Price/Peter Lynch Fair Value 1.90
MD's Price/Peter Lynch Fair Value is ranked higher than
59% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. MD: 1.90 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.09  Med: 1.26 Max: 4.44
Current: 1.9
0.09
4.44
Earnings Yield (Greenblatt) (%) 6.28
MD's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. MD: 6.28 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MD' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 5.9  Med: 9.00 Max: 18.8
Current: 6.28
5.9
18.8
Forward Rate of Return (Yacktman) (%) 16.36
MD's Forward Rate of Return (Yacktman) (%) is ranked higher than
65% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 11.15 vs. MD: 16.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MD' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 14.7  Med: 20.80 Max: 32.3
Current: 16.36
14.7
32.3

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 2,790
EPS($) 3.62 4.12
EPS without NRI($) 3.62 4.12

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:MD.Mexico, PDC.Germany,
Mednax Inc was incorporated in Florida in 2007 and is the successor to Pediatrix Medical Group, Inc., which was incorporated in Florida in 1979. The Company is a provider of physician services including Neonatal Care, Maternal-fetal Care, Pediatric Cardiology Care, Other Pediatric Subspecialty Care and Anesthesia Care. The Company's national network comprised 2,300 affiliated physicians, including 1050 physicians who provide neonatal clinical care, in 34 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company has 200 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. The Company's network includes other pediatric subspecialists, including 120 physicians providing pediatric cardiology care, 100 physicians providing pediatric intensive care, 60 physicians providing hospital-based pediatric care and 15 physicians providing pediatric surgical care. In addition, it has 775 physicians who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. The Company provides clinical care to babies born prematurely or with complications within specific units at hospitals, mainly NICUs, through a team of experienced neonatal physician subspecialists called neonatologists, neonatal nurse practitioners and other pediatric clinicians. The Company provides outpatient and inpatient clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, such as maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers and genetic counselors. It provides inpatient and outpatient pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease as well as adults with congenital heart defects through its affiliated pediatric cardiologist subspecialists and other clinicians such as pediatric nurse practitioners, echocardiographers and other diagnostic technicians, and exercise physiologists. Its network includes pediatric intensivists, who are hospital-based pediatricians with additional education and training in caring for critically ill or injured children and adolescents, and pediatric hospitalists, who are hospital-based pediatricians specializing in inpatient care and management of acutely ill children. The Company provides anesthesia care through a team of experienced physician anesthesiologists, certified registered nurse anesthetists and anesthesia assistants. It has physicians who provide maternal-fetal medical care to expectant mothers experiencing complicated pregnancies and obstetrician hospitalist services in many areas where its affiliated neonat
» More Articles for MD

Headlines

Articles On GuruFocus.com
Midland Exploration Announces the Grant of Options Aug 14 2015 
Midland Begins Field Exploration Work on its Willbob Gold Project in the Labrador Trough Jul 14 2015 
Midland and Its Partners Are Starting Over 10,000 Metres of Drilling in the Abitibi Jan 15 2015 
Midland Options its New Adam Project Located East of Soquem's B26 Zone in Abitibi to Sphinx Resource Dec 16 2014 
Midland Acquires a New Property With Strong Au-Cu Potential East of SOQUEM's B26 Zone in Abitibi Dec 09 2014 
MEDNAX Inc. -- Only 10% Growth Last Week?! Nov 02 2014 
Midland Options its Casault and Jouvex Gold Projects to SOQUEM Oct 21 2014 
Midland Acquires a new Property Along a High Grade Gold Corridor in the Labrador Trough With Histori Oct 15 2014 
Midland and Donner Begin Geophysical Work on the Samson Project South of Balmoral's Grasset Discover Oct 15 2014 
Groups of Gurus Hold 10-Year Low P/B Stocks - ATVI, CHL, MD Dec 20 2013 

More From Other Websites
Tenet Healthcare's Inorganic Growth Impresses, Costs Bother Sep 02 2015
4-star fund manager: Under appreciated mid-caps Aug 25 2015
Mednax acquires Tampa medical practice Aug 20 2015
MEDNAX Announces Acquisition of Anesthesiology Practice in Florida Aug 20 2015
MEDNAX Announces Acquisition of Anesthesiology Practice in Florida Aug 20 2015
Trading Desks Sit Empty in August - Zacks Strategy Aug 10 2015
MEDNAX, INC. Financials Aug 06 2015
10-Q for MEDNAX, Inc. Aug 01 2015
Edited Transcript of MD earnings conference call or presentation 30-Jul-15 2:00pm GMT Jul 31 2015
MEDNAX Inc Earnings Call scheduled for 10:00 am ET today Jul 30 2015
MEDNAX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 30 2015
MEDNAX Reports 2015 Second Quarter EPS of $0.90 Jul 30 2015
Q2 2015 MEDNAX Inc Earnings Release - Before Market Open Jul 30 2015
Mednax tops 2Q profit forecasts Jul 30 2015
Mednax tops 2Q profit forecasts Jul 30 2015
MEDNAX Reports 2015 Second Quarter EPS of $0.90 Jul 30 2015
MEDNAX to Exhibit at the 23rd Annual Health Forum and the American Hospital Association Leadership... Jul 20 2015
MEDNAX to Exhibit at the 23rd Annual Health Forum and the American Hospital Association Leadership... Jul 20 2015
MEDNAX 2015 Second Quarter Conference Call/Webcast Scheduled for Thursday, July 30, 2015 Jul 14 2015
MEDNAX 2015 Second Quarter Conference Call/Webcast Scheduled for Thursday, July 30, 2015 Jul 14 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK